Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

4.

Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.

Wozniak MA, Mee AP, Itzhaki RF.

J Pathol. 2009 Jan;217(1):131-8. doi: 10.1002/path.2449.

PMID:
18973185
5.

Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders.

Carter CJ.

Pathog Dis. 2013 Dec;69(3):240-61. doi: 10.1111/2049-632X.12077. Epub 2013 Sep 2.

6.

β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.

Bourgade K, Garneau H, Giroux G, Le Page AY, Bocti C, Dupuis G, Frost EH, Fülöp T Jr.

Biogerontology. 2015 Feb;16(1):85-98. doi: 10.1007/s10522-014-9538-8. Epub 2014 Nov 7.

PMID:
25376108
7.

Alzheimer's disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner.

Carter CJ.

Int J Alzheimers Dis. 2010 Dec 29;2010:140539. doi: 10.4061/2010/140539.

8.

The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.

Wozniak MA, Frost AL, Itzhaki RF.

Antiviral Res. 2013 Sep;99(3):401-4. doi: 10.1016/j.antiviral.2013.07.003. Epub 2013 Jul 16.

PMID:
23867133
9.

Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer's disease pathogenesis.

Civitelli L, Marcocci ME, Celestino I, Piacentini R, Garaci E, Grassi C, De Chiara G, Palamara AT.

J Neurovirol. 2015 Oct;21(5):480-90. doi: 10.1007/s13365-015-0344-0. Epub 2015 Apr 30.

PMID:
25925093
10.

Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.

Carter CJ.

Neurochem Int. 2008 May;52(6):920-34. doi: 10.1016/j.neuint.2007.11.003. Epub 2007 Nov 23. Review.

PMID:
18164103
11.

Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.

Daulatzai MA.

J Neurosci Res. 2017 Apr;95(4):943-972. doi: 10.1002/jnr.23777. Epub 2016 Jun 27. Review.

PMID:
27350397
12.

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

Lesné SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH.

Brain. 2013 May;136(Pt 5):1383-98. doi: 10.1093/brain/awt062. Epub 2013 Apr 9.

13.

Vaccines for Alzheimer's disease: how close are we?

Janus C.

CNS Drugs. 2003;17(7):457-74. Review.

PMID:
12751917
14.

Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.

Cacabelos R.

Mol Diagn Ther. 2007;11(6):385-405. Review.

PMID:
18078356
15.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative..

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

16.

Molecular genetics of Alzheimer's disease and aging.

Cacabelos R, Fernandez-Novoa L, Lombardi V, Kubota Y, Takeda M.

Methods Find Exp Clin Pharmacol. 2005 Jul;27 Suppl A:1-573.

PMID:
16470248
17.

Anti-Viral Properties of Amyloid-β Peptides.

Bourgade K, Dupuis G, Frost EH, Fülöp T.

J Alzheimers Dis. 2016 Oct 4;54(3):859-878.

PMID:
27392871
18.

Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid beta (Abeta) in rabbit brain.

Sparks DL, Lochhead J, Horstman D, Wagoner T, Martin T.

J Alzheimers Dis. 2002 Dec;4(6):523-9.

PMID:
12515903
19.
20.

Alzheimer's disease pathogenesis and therapeutic interventions.

Parihar MS, Hemnani T.

J Clin Neurosci. 2004 Jun;11(5):456-67. Review.

PMID:
15177383

Supplemental Content

Support Center